A detailed history of Ridgewood Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ridgewood Investments LLC holds 248 shares of ABT stock, worth $27,852. This represents 0.01% of its overall portfolio holdings.

Number of Shares
248
Previous 313 20.77%
Holding current value
$27,852
Previous $35,000 20.0%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

SELL
$111.93 - $119.39 $7,275 - $7,760
-65 Reduced 20.77%
248 $28,000
Q3 2024

Oct 04, 2024

SELL
$100.07 - $118.13 $4,303 - $5,079
-43 Reduced 12.08%
313 $35,000
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $35,859 - $40,028
356 New
356 $36,000
Q1 2023

Apr 25, 2023

BUY
$96.86 - $114.01 $34,385 - $40,473
355 New
355 $35,000
Q2 2021

Jul 22, 2021

SELL
$105.79 - $124.53 $247,337 - $291,151
-2,338 Closed
0 $0
Q1 2021

Apr 27, 2021

SELL
$108.84 - $128.23 $99,044 - $116,689
-910 Reduced 28.02%
2,338 $280,000
Q3 2020

Oct 14, 2020

BUY
$91.64 - $111.29 $8,980 - $10,906
98 Added 3.11%
3,248 $353,000
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $2,297 - $2,940
-30 Reduced 0.94%
3,150 $288,000
Q3 2019

Oct 23, 2019

SELL
$81.84 - $88.74 $8,347 - $9,051
-102 Reduced 3.11%
3,180 $266,000
Q2 2019

Jul 12, 2019

SELL
$72.88 - $85.0 $246,625 - $287,640
-3,384 Reduced 50.77%
3,282 $276,000
Q1 2019

Apr 15, 2019

SELL
$66.22 - $80.06 $222,366 - $268,841
-3,358 Reduced 33.5%
6,666 $533,000
Q3 2018

Oct 30, 2018

BUY
$60.81 - $73.36 $53,573 - $64,630
881 Added 9.64%
10,024 $735,000
Q2 2018

Jul 23, 2018

BUY
$57.57 - $63.54 $42,313 - $46,701
735 Added 8.74%
9,143 $558,000
Q1 2018

Apr 17, 2018

SELL
$56.27 - $63.62 $10,409 - $11,769
-185 Reduced 2.15%
8,408 $504,000
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $412,979 - $460,928
8,593
8,593 $459,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ridgewood Investments LLC Portfolio

Follow Ridgewood Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.